EU regulators: J&J vaccine booster OK to give after 2 months
The European Union drugs regulator said Wednesday that people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The European Union drugs regulator said Wednesday that people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine.
The European Medicines Agency also said the J&J vaccine can be used as a booster dose in people who have had two shots of the vaccines made by Pfizer and Moderna
The recommendations by the agency's human medicines committee give countries more flexibility as they roll out or accelerate booster campaigns to tackle the spread of the new omicron variant.
The agency said in a statement that public health bodies in the 27 EU countries may issue official recommendations on the use of booster doses, “taking into account the local epidemiological situation, availability of vaccines, and emerging effectiveness and the limited safety data for the booster dose.”
The U.S. Food and Drug Administration gave the green light to Johnson & Johnson booster doses in October, both for people who initially received the J&J and vaccine and for people who got immunized with other vaccines.
Johnson & Johnson earlier presented results from a large study that found giving a second dose just two months after the first bumped protection against symptomatic COVID-19 to 94% from 70% in U.S. recipients.